TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION

The invention enables more efficient CTL induction by applying a transdermal preparation containing a WT1 protein-derived cancer antigen peptide and an ether-type additive, which is liquid at 20° C., to a WT1 protein-derived cancer antigen peptide. The ether-type additive is represented by the formu...

Full description

Saved in:
Bibliographic Details
Main Authors TANAKA, Masayasu, SAITO, Koichi, SUGINOBE, Natsuko, MAEDA, Hiroo, YAMAMOTO, Kazumitsu
Format Patent
LanguageEnglish
Published 03.03.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The invention enables more efficient CTL induction by applying a transdermal preparation containing a WT1 protein-derived cancer antigen peptide and an ether-type additive, which is liquid at 20° C., to a WT1 protein-derived cancer antigen peptide. The ether-type additive is represented by the formula (1): R1-O-R2 (1), wherein R1 is a hydrocarbon group having 8-24 carbon atoms, and R2 is a group represented by the formula (2):or a group represented by the formula (3): -(CH2CH2O)mH (3), wherein m is an integer of 1-18.
AbstractList The invention enables more efficient CTL induction by applying a transdermal preparation containing a WT1 protein-derived cancer antigen peptide and an ether-type additive, which is liquid at 20° C., to a WT1 protein-derived cancer antigen peptide. The ether-type additive is represented by the formula (1): R1-O-R2 (1), wherein R1 is a hydrocarbon group having 8-24 carbon atoms, and R2 is a group represented by the formula (2):or a group represented by the formula (3): -(CH2CH2O)mH (3), wherein m is an integer of 1-18.
Author SAITO, Koichi
MAEDA, Hiroo
SUGINOBE, Natsuko
TANAKA, Masayasu
YAMAMOTO, Kazumitsu
Author_xml – fullname: TANAKA, Masayasu
– fullname: SAITO, Koichi
– fullname: SUGINOBE, Natsuko
– fullname: MAEDA, Hiroo
– fullname: YAMAMOTO, Kazumitsu
BookMark eNrjYmDJy89L5WTQCwly9At2cQ3ydfRRcHb0c3YNUnD0C_F0d_VTCHANCPF0cVUICHINcAxyDPH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkYGZkYmRoaOhsbEqQIAfgkocA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022062421A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022062421A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:41:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022062421A13
Notes Application Number: US202117529046
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=US&NR=2022062421A1
ParticipantIDs epo_espacenet_US2022062421A1
PublicationCentury 2000
PublicationDate 20220303
PublicationDateYYYYMMDD 2022-03-03
PublicationDate_xml – month: 03
  year: 2022
  text: 20220303
  day: 03
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies SUMITOMO DAINIPPON PHARMA CO., LTD
RelatedCompanies_xml – name: SUMITOMO DAINIPPON PHARMA CO., LTD
Score 3.3900342
Snippet The invention enables more efficient CTL induction by applying a transdermal preparation containing a WT1 protein-derived cancer antigen peptide and an...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&locale=&CC=US&NR=2022062421A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TCkrfqmszF1-KdG3qJrYr_ZC9jaamIEg3XMW_7yXrdE97S3JwSY5c7nK5D4Bbk-a9vCSlITOvGH1algZHxdzgVBSPuZUPCipjh4NwMMr6L9OHaQs-17EwKk_oj0qOiBxVIL_X6r5e_BuxPOVbubznHzg0f_JT29Ob17Fl4Zkluje0WTTxJq7uunaW6GG8gslYCNPBt9IOKtJUOoCxt6GMS1lsChX_EHYjxFfVR9ASVQf23XXttQ7sBc2XNzYb7lsew10aO2HisThwXjVXVpWJNSdMx88s1CIWpWOPaUjRyFkZnk7gxmepOzJw4tnfPmdZsrlKcgrtal6JM9CIsCgnpsydJktFW5yjaENm6pUojQV_P4fuNkwX28GXcCC7yrGKdKFdf32LK5S0Nb9WBPoFFGB8cQ
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjU-qpJouKGFraUXYigsggIlPExvhKWQmBjaWIx_31naak-9bXaSfUx29tvHzDcA97Ka9bOSlBJnXpEGallKDA_mElOLfJQp2TBXeeyw5w_tZPA6fZq24HMTC9PwhP405IhoUTnae93s14v_Ryyz8a1cPrIPrJo_W7FmiuvbsaLgmiWiOdZoMDEnhmgYWhKJfriS8VgIWce70h4eskecaZ--j3lcymIbVKwj2A-wvao-hlZRdaFjbHKvdeHAW395Y3FtfcsTeIhD3Y9MGnq6Kxg8q0wo6H7svFBfCGgQOyYVUKOBvnp4OoU7i8aGLWHH6d880yTaHiU5g3Y1r4pzEEihqIzInDuNp4pWGENoQ2Pql4jGBZtdQG9XS5e7xbfQsWPPTV3Hf7uCQy5qnKxID9r113dxjahbs5tGWb8SUn9h
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRANSDERMAL+CANCER+ANTIGEN+PEPTIDE+PREPARATION&rft.inventor=TANAKA%2C+Masayasu&rft.inventor=SAITO%2C+Koichi&rft.inventor=SUGINOBE%2C+Natsuko&rft.inventor=MAEDA%2C+Hiroo&rft.inventor=YAMAMOTO%2C+Kazumitsu&rft.date=2022-03-03&rft.externalDBID=A1&rft.externalDocID=US2022062421A1